Michael Gnant

27PUBLICATIONS
193CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Deep learningPredictive and prognostic markersMolecular targetsMedicine, nursing and health curriculum and pedagogy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Mar 18, 2026
Austrian treatment algorithms 2025: CDK 4/6 inhibitors in the adjuvant therapy of HR+/HER2- early breast cancer.

Rupert Bartsch, Clemens Dormann, Daniel Egle

|Jun 09, 2025
Federated Deep Learning Enables Cancer Subtyping by Proteomics.

Zhaoxiang Cai, Emma L Boys, Zainab Noor

|Apr 10, 2025
BRCA1/2 and Other Predisposition Genes in High-Risk Hormone Receptor+/Human Epidermal Growth Factor Receptor 2- Breast Cancer Treated With Endocrine Therapy With or Without Palbociclib: A Secondary PENELOPE-B Study Analysis.

Eric Hahnen, Jan Hauke, Karen Gelmon

|Mar 07, 2025
Augmenting Insufficiently Accruing Oncology Clinical Trials Using Generative Models: Validation Study.

Samer El Kababji, Nicholas Mitsakakis, Elizabeth Jonker

|Jan 17, 2025
Efficacy and Safety of CDK4/6 Inhibitors: A Focus on HR+/HER2- Early Breast Cancer.

Eva Valentina Klocker, Daniel Egle, Rupert Bartsch

|Jan 17, 2025
Neoadjuvant atezolizumab in combination with dual HER2 blockade plus epirubicin in women with early HER2-positive breast cancer: the randomized phase 2 ABCSG-52/ATHENE trial.

Gabriel Rinnerthaler, Daniel Egle, Rupert Bartsch

Pageof 5

Frequent Collaborators

8 joint publications

Martin Filipits

6 joint publications

Marija Balic

5 joint publications

Angela DeMichele

4 joint publications

Sibylle Loibl